|
gptkbp:instanceOf
|
gptkb:company
|
|
gptkbp:CEO
|
gptkb:Liisa_Hurme
|
|
gptkbp:country
|
gptkb:Finland
|
|
gptkbp:division
|
gptkb:Orion_Diagnostica_(until_2018)
gptkb:Orion_Pharma
Fermion
|
|
gptkbp:founded
|
1917
|
|
gptkbp:foundedBy
|
Finnish pharmacists
|
|
gptkbp:headquarters_location
|
gptkb:Espoo,_Finland
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Orion Corporation
|
|
gptkbp:industry
|
pharmaceuticals
|
|
gptkbp:ISIN
|
FI0009014377
|
|
gptkbp:listedOn
|
gptkb:Helsinki_Stock_Exchange
|
|
gptkbp:market
|
gptkb:Europe
gptkb:Finland
|
|
gptkbp:notableProduct
|
gptkb:Comtess
gptkb:Easyhaler
gptkb:Simdax
gptkb:Stalevo
|
|
gptkbp:numberOfEmployees
|
~3500
|
|
gptkbp:parentOrganization
|
independent
|
|
gptkbp:products
|
pharmaceutical drugs
diagnostic tests
active pharmaceutical ingredients
|
|
gptkbp:researchInterest
|
animal health
neurology
oncology
critical care
|
|
gptkbp:revenue
|
EUR 1.3 billion (2023)
|
|
gptkbp:servesArea
|
worldwide
|
|
gptkbp:stockSymbol
|
ORNBV
|
|
gptkbp:type
|
gptkb:public_company
|
|
gptkbp:website
|
https://www.orion.fi/
|
|
gptkbp:bfsParent
|
gptkb:Espoo,_Finland
|
|
gptkbp:bfsLayer
|
5
|